{"database":"ecrin-mdr-crc","file_versions":[],"scores":null,"additional":{"omics_type":["Clinical"],"study_start_year":["2012"],"condition":["Colorectal Cancer","Colorectal Neoplasms"],"disease":["Colorectal Cancer","Colorectal Neoplasms"],"study_type":["Interventional"],"full_dataset_link":["https://newmdr.ecrin.org/Study/2122943"],"location":["China"],"study_start_month":["6"],"keyword":["Irinotecan","Adjuvant chemotherapy","Oxaliplatin","Advanced colorectal cancer","FOLFOX","FOLFIRI"],"repository":["ECRIN MDR"],"study_status":["Not provided"],"additional_accession":[]},"is_claimable":false,"name":"FOLFIRI or mFOLFOX6 in Adjuvant Chemotherapy in Advanced Colorectal Cancer","description":"the aim of this study is to observe the effect of irinotecan-based regimen in patients with advanced colorectal cancer.","dates":{"creation":"2012-06-15"},"accession":"2122943","cross_references":{"ClinicalTrials___gov":["NCT01566942"]}}